Research | OneLook Acronym Finder |
Serial Number | 79325151 |
Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
2021-09-23 | Application Filed |
2021-11-11 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-11-11 | Status: Live/Pending |
2021-11-12 | Transaction Date |
Owner: | QUANTEL MEDICAL |
Address | 11 rue du Bois Joli, CS 40015 F-63808 COURNON D'AUVERGNE CEDEX FR |
Legal Entity Type | Société Par Actions Simplifiée (sas) |
Legal Entity State | FR |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
260513 | Triangles, exactly two triangles; Two triangles |
260521 | Triangles that are completely or partially shaded |
260525 | Triangles with one or more curved sides |
260721 | Diamonds that are completely or partially shaded |
260728 | Diamond shapes (miscellaneous overall shape); Miscellaneous designs with overall diamond shape, including letters forming or comprising a diamond |
261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0101 | Medical laser for glaucoma and secondary cataract treatment |
DM0000 | The mark consists of the wording "CAPSULO" in black with a green stylized diamond and black curved underline at the bottom of the letter "O". The color white represents background and/or transparent areas and is not claimed as a feature of the mark. |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-11-11 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-11-12 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2021-11-16 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2022-03-24 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-03-24 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-03-25 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2022-05-04 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-05-04 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2022-05-25 | 9 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-09-29 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-09-29 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-09-30 | 12 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-10-19 | 13 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-11-02 | 14 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2022-11-22 | 15 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-11-22 | 16 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2023-02-07 | 17 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-02-07 | 18 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2023-05-07 | 19 FICR P: |
FINAL DISPOSITION PROCESSED | 2023-05-08 | 20 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2023-05-08 | 21 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-05-30 | 22 FINV P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.